# Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus

> **NCT02549924** · PHASE2 · TERMINATED · sponsor: **University of Guadalajara** · enrollment: 22 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Resveratrol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02549924
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09
- **Primary completion:** 2018-01-01
- **Final completion:** 2018-02-01
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** no financial support
- **Last updated:** 2018-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02549924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02549924, "Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02549924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*